Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-061042
Filing Date
2011-03-09
Accepted
2011-03-09 17:23:43
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1004033
2 RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT, AS AMENDED. dex31.htm EX-3.1 57887
3 SUMMARY OF DIRECTOR COMPENSATION dex106.htm EX-10.6 11827
4 SUMMARY OF 2011 BONUS TARGETS dex107.htm EX-10.7 3939
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3356
6 CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO EXCHANGE ACT RULE 13A-14(A) dex311.htm EX-31.1 10106
7 CERTIFICATION OF CFO PURSUANT TO EXCHANGE ACT RULE 13A-14(A) dex312.htm EX-31.2 10343
8 CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 2942
9 CERTIFICATION OF THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 2924
11 GRAPHIC g146557covltrpg1a.jpg GRAPHIC 8390
12 GRAPHIC g146557covltrpg1bv2.jpg GRAPHIC 16874
13 GRAPHIC g146557g28i32.jpg GRAPHIC 45420
14 GRAPHIC g146557g70i15.jpg GRAPHIC 60320
  Complete submission text file 0001193125-11-061042.txt   1289352
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34217 | Film No.: 11676014
SIC: 2834 Pharmaceutical Preparations